Stay updated on Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page
- Check3 days agoChange DetectedPlatform revision updated from v3.6.0 to v3.6.2, indicating an updated build of the site. This change does not modify study data or visible content on the page.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now marks recruitment as closed ('No longer looking for participants') and adds user guidance sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'), while updating the revision label to v3.6.0 and standardizing the Intervention/Treatment heading (replacing Intervention / Treatment with Intervention/Treatment).SummaryDifference0.4%

- Check24 days agoChange DetectedRevision: v3.5.5 is now displayed, replacing Revision: v3.5.4. This indicates a minor site version update to the platform's metadata with no changes to study content.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page's revision indicator was updated from v3.5.3 to v3.5.4, representing a minor, internal update to the ClinicalTrials.gov page rather than a modification to study data or visible content.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page’s footer “Revision” version was increased from v3.5.2 to v3.5.3, indicating a backend/software release update without changing the study information presented.SummaryDifference0.1%

- Check74 days agoChange DetectedAddition: Revision v3.5.2; Deletion: Revision v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page.